<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03126058</url>
  </required_header>
  <id_info>
    <org_study_id>BE2015687C</org_study_id>
    <nct_id>NCT03126058</nct_id>
  </id_info>
  <brief_title>Enhanced Recovery After Surgery Program for Colorectal Cancer: a Multi-center Study (ERASC1)</brief_title>
  <acronym>ERASC1</acronym>
  <official_title>Enhanced Recovery After Surgery Program for Colorectal Cancer: a Multi-center Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jinling Hospital, China</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Jinling Hospital, China</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is aimed to evaluate the safety of applying enhanced recovery after surgery for
      colorectal cancer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In China, Europe and America, colorectal cancer is one of common malignant tumors. It is very
      important for treatment of colorectal cancer to enhance the quality of treatment, increase
      patients' survival rate and improve the life quality. So far, surgical resection is optimal
      treatment for patients with colorectal cancer. As a result, increasing the quality of surgery
      and improving the perioperative managements have a great influence on patients received a
      coloproctectomy. Investigators have spent over ten years studying enhanced recovery after
      surgery programs for colorectal cancer and have got some successful experience. Investigators
      found enhanced recovery after surgery can accelerate patients' recovery without increasing
      complications. This study is the first multi-center study of enhanced recovery after surgery
      for colorectal cancer in China. During this period, the study is aimed to evaluate the safety
      of applying enhanced recovery after surgery for colorectal cancer.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 21, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2018</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Patients will receive enhanced recovery after surgery programs.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>occurrence rate of severe complications</measure>
    <time_frame>1 month</time_frame>
    <description>including death, anastomotic fistula, intra-abdominal hemorrhage, hemorrhage of digestive tract and complications need a reoperation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Occurrence rate of ordinary complications</measure>
    <time_frame>1 month</time_frame>
    <description>Except severe complications, Clavien-Dindo classification ≥Ⅱ complications need not reoperation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Readmission rate within 30 days after discharge</measure>
    <time_frame>1 month</time_frame>
    <description>Readmission rate within 30 days after discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ideal postoperative length of hospital stay</measure>
    <time_frame>1 month</time_frame>
    <description>reach discharge criteria</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Actual postoperative length of hospital stay</measure>
    <time_frame>1 month</time_frame>
    <description>Actual postoperative length of hospital stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operative time</measure>
    <time_frame>1 day</time_frame>
    <description>duration of operation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood loss</measure>
    <time_frame>1 day</time_frame>
    <description>Blood loss</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraoperative infusion</measure>
    <time_frame>1 day</time_frame>
    <description>Intraoperative infusion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>TNM classification</measure>
    <time_frame>1 week</time_frame>
    <description>classification of tumor</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of dissected lymph node</measure>
    <time_frame>1 week</time_frame>
    <description>Number of dissected lymph node</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first flatus</measure>
    <time_frame>2 week</time_frame>
    <description>Bowel function recovery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first defecation</measure>
    <time_frame>2 week</time_frame>
    <description>Bowel function recovery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first semi-liquid diet</measure>
    <time_frame>2 week</time_frame>
    <description>Bowel function recovery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first off-bed activity</measure>
    <time_frame>1 week</time_frame>
    <description>Postoperative activity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time of off-bed activity per day</measure>
    <time_frame>1 week</time_frame>
    <description>Postoperative activity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Distance of off-bed activity per day</measure>
    <time_frame>1 week</time_frame>
    <description>Postoperative activity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain</measure>
    <time_frame>1 week</time_frame>
    <description>VAS classification</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital cost</measure>
    <time_frame>1 month</time_frame>
    <description>Hospital cost</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Management of catheters</measure>
    <time_frame>1 month</time_frame>
    <description>including nasogastric tube, catheter, intraperitoneal drain, infusion tube</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Preoperative length of hospital stay</measure>
    <time_frame>1 month</time_frame>
    <description>Preoperative length of hospital stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CD3+</measure>
    <time_frame>1 week</time_frame>
    <description>Immune indicators</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CD4+</measure>
    <time_frame>1 week</time_frame>
    <description>Immune indicators</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CD4+/CD8+</measure>
    <time_frame>1 week</time_frame>
    <description>Immune indicators</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IL-6</measure>
    <time_frame>1 week</time_frame>
    <description>Inflammatory indicators</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CRP</measure>
    <time_frame>1 week</time_frame>
    <description>Inflammatory indicators</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Albumin</measure>
    <time_frame>1 week</time_frame>
    <description>Nutritional indicators</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prealbumin</measure>
    <time_frame>1 week</time_frame>
    <description>Nutritional indicators</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Transferrin</measure>
    <time_frame>1 week</time_frame>
    <description>Nutritional indicators</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hb</measure>
    <time_frame>1 week</time_frame>
    <description>Nutritional indicators</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>WBC</measure>
    <time_frame>1 week</time_frame>
    <description>Nutritional indicators</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PLT</measure>
    <time_frame>1 week</time_frame>
    <description>Nutritional indicators</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HCT</measure>
    <time_frame>1 week</time_frame>
    <description>Nutritional indicators</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood glucose</measure>
    <time_frame>1 week</time_frame>
    <description>Nutritional indicators</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procalcitonin</measure>
    <time_frame>1 week</time_frame>
    <description>Infectious indicator</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Colorectal Cancer</condition>
  <arm_group>
    <arm_group_label>enhanced recovery after surgery</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>enhanced recovery after surgery includes:
Multimodal analgesia
Early oral intake A: Drink water after anesthetic awareness. B: Recover semi-liquid diet
Management of nasogastric tube and catheter A: Not indwell nasogastric tube conventionally. B: Remove catheter early.
Early activity
Perioperative controlled infusion A: Load carbohydrate preoperatively B: No preoperative bowel preparation for right hemicolectomy, Miles rectectomy and Hartman rectectomy, simple cleansing enema for left hemicolectomy,sigmoidectomy and Dixon rectectomy; C: Fast six hours before surgery, no drink two hours before surgery D: Intraoperative liquid management: 3-6ml/kg/h, determined by anesthetists E: Stop intravenous infusion upon 2000-2500ml water and semiliquid diet being taken</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>enhanced recovery after surgery</intervention_name>
    <description>Patients will undergo enhanced recovery after surgery programs.</description>
    <arm_group_label>enhanced recovery after surgery</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Requirements of informed consent and assent of participant, parent or legal guardian
             as applicable

          2. Patients with colorectal cancer scheduled for radical coloproctectomy and between the
             age of 18 and 75 years old without considering sex

          3. ASA physical status I-III

          4. Participants can follow the drug doses and visit plan

        Exclusion Criteria:

          1. Patients certified by a doctor that doesn't fit to participate in this study.

          2. Patients with ischemic heart disease, cerebrovascular disease and peripheral vascular
             disease, or their cardiac function &gt; II (NYHA) patients, patients received CABG
             recently, and patients with severe hypertension (systolic pressure≥180mmHg or
             diastolic pressure≥110mmHg).

          3. Patients with colorectal cancer with distant metastasis.

          4. Patients with severe infection, respiratory dysfunction, coagulation disorders, severe
             liver and renal dysfunction (Child - Pugh≥ 10; creatinine clearance &lt; 25 ml/min).

          5. Patients allergic to common drugs, such as opioids, non-steroidal drugs,
             cephalosporins, etc.

          6. Patients with operations of gastrointestinal cancer and complicated abdominal
             operations.

          7. Patients complicated by colorectal cancer with complications such as hemorrhage,
             perforation, obstruction.

          8. Patients with dyscrasia and severe malnutrition (albumin≤30g/L, weight loss in half a
             year＞10%, SGA classification C, BMI＜18, Hb＜70g/L).

          9. Patients with metabolic complications caused by diabetes.

         10. Patients can't finish enhanced recovery after surgery programs and have
             contraindications of enhanced recovery after surgery.

         11. Pregnancy and lactation women, or have a pregnancy plan within a month after the test
             of the subjects (also including male participants).

         12. Patients participated other subjects 3 months before this subject.

         13. Sponsors or researchers directly involved in the testing or their family members.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zhi-Wei JIANG</last_name>
    <role>Principal Investigator</role>
    <affiliation>Jinling Hospital, Medical School of Nanjing University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jian ZHAO</last_name>
    <role>Study Director</role>
    <affiliation>Jinling Hospital, Medical School of Nanjing University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gang WANG</last_name>
    <role>Study Director</role>
    <affiliation>Jinling Hospital, Medical School of Nanjing University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jiang LIU</last_name>
    <role>Study Director</role>
    <affiliation>Jinling Hospital, Medical School of Nanjing University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Zhi-Wei JIANG, Ph.D.</last_name>
    <phone>8602580860034</phone>
    <email>nzjiangzhiwei@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jian ZHAO, Ph.D.</last_name>
    <phone>8602580860034</phone>
    <email>zhaojiangogo@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The First People's Hospital of Changzhou</name>
      <address>
        <city>Changzhou</city>
        <state>Jiangsu</state>
        <zip>213003</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Qicheng LU, M.D.</last_name>
      <email>changyiluqicheng@sina.com</email>
    </contact>
    <investigator>
      <last_name>Qicheng LU, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Changzhou Second People's Hospital Affiliated to Nanjing Medical University</name>
      <address>
        <city>Changzhou</city>
        <state>Jiangsu</state>
        <zip>213164</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Liming TANG, M.D.</last_name>
      <email>drtanglm@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Liming TANG, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The First People's Hospital of Lianyungang City</name>
      <address>
        <city>Lianyungang</city>
        <state>Jiangsu</state>
        <zip>222002</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Huiyu CHEN, M.D.</last_name>
    </contact>
    <contact_backup>
      <last_name>Zengtao BAO, M.D.</last_name>
    </contact_backup>
    <investigator>
      <last_name>Huiyu CHEN, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Second People's Hospital of Lianyungang City</name>
      <address>
        <city>Lianyungang</city>
        <state>Jiangsu</state>
        <zip>222006</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yongchang MIAO, M.D.</last_name>
      <email>lygmiao@sina.com</email>
    </contact>
    <contact_backup>
      <last_name>Gang WANG</last_name>
      <phone>M.D.</phone>
    </contact_backup>
    <investigator>
      <last_name>Yongchang MIAO, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nanjing First Hospital</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hongyong CAO, M.D.</last_name>
      <email>caohongy6167@163.com</email>
    </contact>
    <investigator>
      <last_name>Hongyong CAO, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Jinling Hospital, Medical School of Nanjing University</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210002</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhi-Wei JIANG, Ph.D.</last_name>
      <phone>8602580860034</phone>
      <email>nzjiangzhiwei@163.com</email>
    </contact>
    <contact_backup>
      <last_name>Jian ZHAO, Ph.D.</last_name>
      <phone>8602580860034</phone>
      <email>zhaojiangogo@163.com</email>
    </contact_backup>
    <investigator>
      <last_name>Zhi-Wei JIANG, Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gang WANG, Ph.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jian ZHAO, Ph.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jiang LIU, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Zhongda Hospital, Southeast University</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210009</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jingmin WANG, M.D.</last_name>
      <email>wjm730222@163.com</email>
    </contact>
    <investigator>
      <last_name>Jingmin WANG, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Second Affiliated Hospital of Nanjing Medical University</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210011</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jianping ZHANG, M.D.</last_name>
      <email>zhang_jp64@aliyun.com</email>
    </contact>
    <contact_backup>
      <last_name>Qinghong ZHAO, M.D.</last_name>
      <email>njzhqh@sina.com</email>
    </contact_backup>
    <investigator>
      <last_name>Jianping ZHANG, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Qinghong ZHAO, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Nanjing Medical University</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210029</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lizong SHEN, M.D.</last_name>
      <email>shenlz@njmu.edu.cn</email>
    </contact>
    <contact_backup>
      <last_name>Yongbin DING, M.D.</last_name>
    </contact_backup>
    <investigator>
      <last_name>Lizong SHEN, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Suqian People's Hospital, Nanjing Drum Tower Hospital</name>
      <address>
        <city>Suqian</city>
        <state>Jiangsu</state>
        <zip>223800</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jianqiang WU, M.D.</last_name>
      <email>wjq-10@163.com</email>
    </contact>
    <investigator>
      <last_name>Jianqiang WU, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Suzhou Municipal Hospital</name>
      <address>
        <city>Suzhou</city>
        <state>Jiangsu</state>
        <zip>215000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xinhua GU, M.D.</last_name>
    </contact>
    <contact_backup>
      <last_name>Renbin SHEN</last_name>
      <phone>M.D.</phone>
    </contact_backup>
    <investigator>
      <last_name>Xinhua GU, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Second Affiliated Hospital of Soochow University</name>
      <address>
        <city>Suzhou</city>
        <state>Jiangsu</state>
        <zip>215004</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Haorong WU, M.D.</last_name>
      <email>wuhaorong666@126.com</email>
    </contact>
    <contact_backup>
      <last_name>Yongyou WU, M.D.</last_name>
      <email>13338706607@126.com</email>
    </contact_backup>
    <investigator>
      <last_name>Haorong WU, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yongyou WU, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Soochow University</name>
      <address>
        <city>Suzhou</city>
        <state>Jiangsu</state>
        <zip>215006</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xinguo ZHU, M.D.</last_name>
      <email>zxg45@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Zhongqi MAO</last_name>
      <phone>M.D.</phone>
      <email>maozq31@hotmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Xinguo ZHU, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Zhongqi MAO, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The First People's Hospital of Taicang</name>
      <address>
        <city>Suzhou</city>
        <state>Jiangsu</state>
        <zip>215400</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yi WANG, M.D.</last_name>
    </contact>
    <contact_backup>
      <last_name>Bing WANG, M.D.</last_name>
    </contact_backup>
    <investigator>
      <last_name>Yi WANG, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Second People's Hospital of Changshu City</name>
      <address>
        <city>Suzhou</city>
        <state>Jiangsu</state>
        <zip>215500</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guoqiang ZHOU, M.D.</last_name>
    </contact>
    <investigator>
      <last_name>Guoqiang ZHOU, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Zhangjiagang First People's Hospital</name>
      <address>
        <city>Suzhou</city>
        <state>Jiangsu</state>
        <zip>215600</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shusheng WANG, M.D.</last_name>
      <email>Wsszyy2005@163.com</email>
    </contact>
    <investigator>
      <last_name>Shusheng WANG, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Liang ZHOU, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Taizhou People's Hospital</name>
      <address>
        <city>Taizhou</city>
        <state>Jiangsu</state>
        <zip>225300</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Qinghong LIU, M.D.</last_name>
    </contact>
    <contact_backup>
      <last_name>Honggang WANG, M.D.</last_name>
    </contact_backup>
    <investigator>
      <last_name>Qinghong LIU, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The 101 Hospital of the Chinese People's Liberation Army</name>
      <address>
        <city>Wuxi</city>
        <state>Jiangsu</state>
        <zip>214000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guozhong WU, M.D.</last_name>
      <email>jfj101hwugz@sina.cn</email>
    </contact>
    <investigator>
      <last_name>Guozhong WU, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Affiliated Hospital of Jiangnan University, The Forth People's Hospital of Wuxi</name>
      <address>
        <city>Wuxi</city>
        <state>Jiangsu</state>
        <zip>214062</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bojian FEI, M.D.</last_name>
      <email>wx4yfbj@163.com</email>
    </contact>
    <investigator>
      <last_name>Bojian FEI, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Xuzhou Central Hospital</name>
      <address>
        <city>Xuzhou</city>
        <state>Jiangsu</state>
        <zip>221009</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiaopeng LV, M.D.</last_name>
      <email>18952171977@126.com</email>
    </contact>
    <investigator>
      <last_name>Xiaopeng LV, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northern Jiangsu People's Hospital</name>
      <address>
        <city>Yangzhou</city>
        <state>Jiangsu</state>
        <zip>225001</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ping CHEN, M.D.</last_name>
      <email>chen86ky@126.com</email>
    </contact>
    <contact_backup>
      <last_name>Xinxin LIU, M.D.</last_name>
    </contact_backup>
    <investigator>
      <last_name>Ping CHEN, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Daorong WANG, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Xinxin LIU, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Affiliated Hospital of Jiangsu University</name>
      <address>
        <city>Zhenjiang</city>
        <state>Jiangsu</state>
        <zip>212001</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jixiang CHEN, M.D.</last_name>
      <email>cyok9@163.com</email>
    </contact>
    <investigator>
      <last_name>Jixiang CHEN, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Affiliated People's Hospital of Jiangsu University</name>
      <address>
        <city>Zhenjiang</city>
        <state>Jiangsu</state>
        <zip>212002</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pengcheng JIANG, M.D.</last_name>
      <email>jpc18906106623@126.com</email>
    </contact>
    <contact_backup>
      <last_name>Shouliang ZHANG, M.D.</last_name>
    </contact_backup>
    <investigator>
      <last_name>Pengcheng JIANG, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 20, 2017</study_first_submitted>
  <study_first_submitted_qc>April 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 24, 2017</study_first_posted>
  <last_update_submitted>April 27, 2018</last_update_submitted>
  <last_update_submitted_qc>April 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 30, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Jinling Hospital, China</investigator_affiliation>
    <investigator_full_name>Jian ZHAO</investigator_full_name>
    <investigator_title>Vice director of Research Institute of General Surgery</investigator_title>
  </responsible_party>
  <keyword>enhanced recovery after surgery</keyword>
  <keyword>colorectal cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

